---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-026732"
form_type: "8-K"
ticker: "SANA"
cik: "0001770121"
company_name: "Sana Biotechnology, Inc."
filed_at: "2023-06-07T23:59:59+00:00"
generated_at: "2026-06-14T05:57:54.362355+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Sana Biotechnology presents corporate update at Jefferies conference; no specific data in filing

## Summary
- Filed updated corporate presentation as Exhibit 99.1 for Jefferies Healthcare Conference on June 7, 2023.
- No financial results, guidance changes, or pipeline milestones explicitly disclosed in the 8-K or provided exhibit.
- Investors should refer to the full presentation for details on strategy and pipeline.

## SEC filing metadata
- accession: 0000950170-23-026732
- form_type: 8-K
- ticker: SANA
- cik: 0001770121
- company_name: Sana Biotechnology, Inc.
- filed_at: 2023-06-07T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1770121/000095017023026732/0000950170-23-026732-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1770121/000095017023026732/sana-20230607.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-026732
- JSON: https://secwatch.observer/filing/0000950170-23-026732.json
- Plain text: https://secwatch.observer/filing/0000950170-23-026732.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.